Relay Therapeutics, Inc.
RLAY
Helyezés a részvények között
#4011
Relay Therapeutics, Inc. is a precision medicine company currently engaged in... Relay Therapeutics, Inc. is a precision medicine company currently engaged in clinical trials. Its central mission involves revolutionizing the drug discovery process, with a particular focus on enhancing the creation of small molecule therapies for specific types of cancer and genetic conditions. The company's pipeline features several promising drug candidates: RLY-4008, an orally administered small molecule designed to inhibit fibroblast growth factor receptor 2 (FGFR2), which is undergoing its initial human trials for patients with advanced or metastatic solid tumors exhibiting FGFR2 alterations; RLY-2608, a leading program targeting mutant phosphoinositide 3 kinase alpha (PI3Ka); and RLY-1971, another oral small molecule, an inhibitor of SHP2 (protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-2), currently in Phase 1 trials for individuals with advanced solid tumors. Relay Therapeutics has established strategic partnerships, including a collaboration with D. E. Shaw Research, LLC, which utilizes computational modeling to analyze protein motion for the identification and development of therapeutic compounds. Furthermore, an agreement with Genentech, Inc. supports the development and commercialization of RLY-1971. Founded in 2015 as Allostery, Inc., the company rebranded to Relay Therapeutics, Inc. in December of that year and maintains its headquarters in Cambridge, Massachusetts.
Részvényárfolyam
$18.26
Piaci kapitalizáció
$4.00B
Változás (1 nap)
-0.84%
Változás (1 év)
181.71%
Ország
US
Kereskedés Relay Therapeutics, Inc. (RLAY)
Kategória
Healthcare
Relay Therapeutics, Inc. (RLAY) részvényárfolyamának története
Legmagasabb napi záróár: $17.94 ekkor: 2026-10-01
Legalacsonyabb napi záróár: $37.16 ekkor: 2020-07-01
Legalacsonyabb napi záróár: $37.16 ekkor: 2020-07-01
Relay Therapeutics, Inc. részvényárfolyamának története 2020 és 2026 között
Éves részvényárfolyam teljesítmény
| Év | Teljesítmény |
|---|---|
| 2026 (TTM) | 62.07% |
| 2025 | 81.45% |
| 2024 | -55.68% |
| 2023 | -38.67% |
| 2022 | -45.02% |
| 2021 | -37.95% |
| 2020 | 0.00% |
Hasonló cégek vagy versenytársak részvényárai
| Vállalat | Részvényár | Változás 1év% | Ország |
|---|---|---|---|
| $535.55 | 25.59% |
US
|
|
| $187.49 | 598.30% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $876.18 | 7.62% |
NL
|
